Genterpret's Death

Genterpret raised a round of funding on November 01, 2013. Investors include Dead.

Genterpret helps pharmaceutical companies quickly and cost effectively gain access to genetic and clinical datasets linking genetics to drug response. We quickly enroll patients through direct outreac…

Articles about Genterpret's Death: